These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 31752734)

  • 1. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
    Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
    BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
    Yang WL; Bose B; Zhang L; Mcstea M; Cho Y; Fahim M; Hawley CM; Pascoe EM; Johnson DW
    PLoS One; 2019; 14(8):e0221531. PubMed ID: 31442267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases.
    Mallett A; Tang W; Hart G; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Clayton PA; Johnson DW
    Am J Nephrol; 2015; 42(3):177-84. PubMed ID: 26418732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis.
    Angelo JR; Bell CS; Braun MC
    Am J Kidney Dis; 2011 Feb; 57(2):291-9. PubMed ID: 21215503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Zhang L; Lee G; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Kidney Int; 2016 Jun; 89(6):1337-45. PubMed ID: 27165824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.
    Allen PJ; Chadban SJ; Craig JC; Lim WH; Allen RDM; Clayton PA; Teixeira-Pinto A; Wong G
    Kidney Int; 2017 Aug; 92(2):461-469. PubMed ID: 28601198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification.
    Alasfar S; Carter-Monroe N; Rosenberg AZ; Montgomery RA; Alachkar N
    BMC Nephrol; 2016 Jan; 17():7. PubMed ID: 26754737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.
    Tang W; Mohandas J; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
    BMC Nephrol; 2012 Dec; 13():164. PubMed ID: 23206870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased glomerulonephritis recurrence after living related donation.
    Kennard AL; Jiang SH; Walters GD
    BMC Nephrol; 2017 Jan; 18(1):25. PubMed ID: 28095803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
    Hruskova Z; Pippias M; Stel VS; Abad-Díez JM; Benítez Sánchez M; Caskey FJ; Collart F; De Meester J; Finne P; Heaf JG; Magaz A; Palsson R; Reisæter AV; Salama AD; Segelmark M; Traynor JP; Massy ZA; Jager KJ; Tesar V
    Am J Kidney Dis; 2019 Feb; 73(2):184-193. PubMed ID: 30122544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.
    Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; de Zoysa JR; Johnson DW
    Nephrol Dial Transplant; 2013 Feb; 28(2):455-61. PubMed ID: 23182810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Membranoproliferative Glomerulonephritis After Kidney Transplantation: Risk Factors and Impact on Graft Survival.
    de Paula LC; Mazzali M; de Sousa MV
    Ann Transplant; 2023 Jul; 28():e940502. PubMed ID: 37461201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause.
    Lim WH; Wong G; McDonald SP; Chakera A; Luxton G; Isbel NM; Pilmore HL; Barbour T; Hughes P; Chadban SJ
    Sci Rep; 2018 Jun; 8(1):9021. PubMed ID: 29899355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
    Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
    Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.
    Tang W; Bose B; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; Peh CA; Johnson DW
    Clin J Am Soc Nephrol; 2013 May; 8(5):773-80. PubMed ID: 23349331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal allograft survival in patients with oxalosis.
    Cibrik DM; Kaplan B; Arndorfer JA; Meier-Kriesche HU
    Transplantation; 2002 Sep; 74(5):707-10. PubMed ID: 12352890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry.
    Pippias M; Stel VS; Aresté-Fosalba N; Couchoud C; Fernandez-Fresnedo G; Finne P; Heaf JG; Hoitsma A; De Meester J; Pálsson R; Ravani P; Segelmark M; Traynor JP; Reisæter AV; Caskey FJ; Jager KJ
    Transplantation; 2016 Sep; 100(9):1955-62. PubMed ID: 26588008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study.
    Pladys A; Bayat S; Couchoud C; Vigneau C; McDonald S
    BMC Nephrol; 2019 May; 20(1):156. PubMed ID: 31064344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.